5Cook MG, Dixon MF. An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut, 1973, 14:255-262.
6Dube AK, Cross SS, Lobo AJ. Audit of the histopathological diagnosis of non-neoplastic colorectal biopsies: achievable standards for the diagnosis of inflammatory bowel disease. J Clin Pathol, 1998, 51:378-381.
7Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet, 1980, 1:514.
8Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med, 1994, 330: 811-815.
9Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med, 1999, 5: 793-802.
5Kjeldsen J, Lassen JF, Brandslund i, et al. Maykers of coagulation andfibrinolysis as measures of disease activity in inflammatory bowel disease [J]. Scand J Gastroenterol, 1998, 33 (6): 637-643.
6Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis [ J ]. Pathophysiol Haemost Thromb, 2004, 33 (526): 375-381.
7Fagerstam JP, Whiss PA, Strom M, et al. Expression of platelet P-se- lectin and detection of soluble P-selectin, NPY and RANTES in pa- tients with inflammatory bowel disease [ J]. Inflamm Res, 2000, 49 (8) : 466-472.
8Larson TB, Nielsen JN, Fredhohn L, et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease [ J]. Pathophysiol Haemost Thromb, 2002, 32 ( 2 ) : 92-96.
9Colloins CE, Rampton DS. Review article: platelets in inflammatory bowel disease-pathogenetic role and therapeutic implications [ J ]. Ali- ment Pharmacol Ther, 1997, 11 (2) : 237-247.
10Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression [J]. Arterioscler Thromb Vasc Biol, 2000, 20(10): 2322-2328.
